Abstract
Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have